Jenny Whitworth, MD
Gynecologic Oncology · Jacksonville, FLNPI 1811105372
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,433 of the $6,598 with a category attached, or 67.2%. 5 manufacturers reported payments, led by Johnson & Johnson at 52.2% of the total. 2025 is the largest year on record at $5,449, more than ten times the $99 reported in 2022.
Across 34 payments — averaging $194.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Intuitive Surgical$3K
- Medical Device Business Services, Inc.$294
- Medtronic$110
- Takeda Pharmaceuticals U.S.A., Inc.$99
Across 99 payments — averaging $4288.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Clovis Oncology, Inc.$337K
- Seagen Inc.$55K
- Pharmaand GmbH$31K
- Merck$1K
- Genmab U.S., Inc.$810
What the payments were for
- Travel & lodging$4,43367%
- Food & beverage$1,31620%
- Education$84913%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 11 | $3,447 |
| Intuitive Surgical | 16 | $2,647 |
| Medical Device Business Services, Inc. | 5 | $294 |
| Medtronic | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $99 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,577
- DAVINCI XI$750
- Monarch Platform$218
How this compares
$6,598 in reported general payments places this provider in the 65th percentile of 117 gynecologic oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 13 | $244 |
| Oxycodone Hcl | 21 | $80 |
| Alprazolam | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Jacksonville
- Martin MartinoJacksonville$957K
- Tri DinhJacksonville$8K
- Matthew RobertsonJacksonville$6K
- Bradley MonkWest Palm Beach$2.5M
- Brian SlomovitzFort Lauderdale$519K
- Ricardo EstapeMiami$457K
- Robert HollowayOrlando$432K
- Shelly SewardOrlando$349K
- Edward GrendysFort Myers$341K
- Jonathan BlackMiramar$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.